| Literature DB >> 29287728 |
Pierre Krolak-Salmon1, Laurent Letrilliart2, Mathieu Ceccaldi3, Sandrine Andrieu4, Olivier Guérin5, Bruno Dubois6, Bruno Brochet7, Pierre Vandel8, Claude Jeandel9, Armelle Leperre-Desplanques10, Michel Clanet11, Pierre-Louis Druais12.
Abstract
Neurocognitive disorders leading to progressive cognitive, functional and behavioural impairment are often undiagnosed or diagnosed lately. But tailored care and therapeutics help in implementing secondary and tertiary prevention dynamics aiming at preserving quality of life and delaying, anticipating or preventing behavioural crisis and severe stages of dementia. Moreover, the diagnosis of numerous diseases induces specific care and therapeutics, as well access to research and clinical trials. For the first time, the representatives of the National College of General Practitioners, the French Federation of Memory Centres, the French Federation of Gerontology and Geriatrics, the French Federation of Neurology, the French Society of Psychogeriatrics and the national plan on neurodegenerative diseases propose a graduated and tailored diagnosis strategy involving primary care and specialists of neurocognitive disorders. This strategy has been built in the context of the national plan on neurodegenerative diseases, the European Joint Action "Act on dementia", and has been consensually agreed after a seminar animated by the National College of General Practitioners in March 2017.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29287728 DOI: 10.1016/j.lpm.2017.10.029
Source DB: PubMed Journal: Presse Med ISSN: 0755-4982 Impact factor: 1.228